Provide a genomic-based, comprehensive, individualized risk assessment for early-stage cancers in specific settings.
Find and monitor cancer after treatment and get insights to guide therapy selection.
Understand how genomic testing can help to guide your individualized treatment options.
Experience our comprehensive portfolio of diagnostic tests through the lens of a specific cancer type
See how Precision Oncology is enabling more personalize cancer care
100421, 100441, 302774
The Oncotype DX Breast Recurrence Score Test is an in vitro diagnostic device, CE marked under Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices.
LBL-10356_IFU (English) LBL-10359_IFU (German)
LBL-10356_PI (English) LBL-10359_PI (German)
You are now leaving this site. Any third party link you select from this site may take you to a website that is not affiliated with Exact Sciences.
